Search results for "Atrial Fibrillation"
Troponin level may help predict mortality in patients admitted with afib
Troponin levels were associated with risk for death, and coronary angiography was associated with both higher troponin levels and lower mortality.
https://acphospitalist.acponline.org/weekly/archives/2020/04/01/6.htm
1 Apr 2020
Studies estimate risks of bleeding, death in patients with cancer and atrial fibrillation
One recent study compared the predictive value of the HAS-BLED, ATRIA, and ORBIT scores in patients with cancer and afib, while another looked at clot, bleeding, and mortality risk with warfarin versus a direct-acting oral anticoagulant in patients with both conditions.
https://acphospitalist.acponline.org/archives/2022/12/07/studies-estimate-risks-of-bleeding-death-in-patients-with-cancer-and-atrial-fibrillation.htm
7 Dec 2022
Elevated troponin I levels during sepsis may indicate risk for postsepsis CV complications
A U.S. retrospective study looked at rates of atherosclerotic disease, atrial fibrillation, and heart failure in the year after sepsis in patients with elevated troponin I levels and no previous diagnosis of cardiovascular (CV) disease.
https://acphospitalist.acponline.org/weekly/archives/2021/06/09/2.htm
9 Jun 2021
Fewer health care resources needed after ablation for afib, study finds
In an observational analysis, patients with afib who underwent ablation had fewer hospitalizations and ED visits in the two years after the procedure versus the year before it.
https://acphospitalist.acponline.org/archives/2023/09/20/fewer-health-care-resources-needed-after-ablation-for-afib-study-finds.htm
20 Sep 2023
Duty hours, infective endocarditis
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2019/08/recent-research.htm
15 Aug 2019
New COVID-19 boosters, biosimilar for MS OK’ed
The FDA approved updated COVID-19 vaccines and the first-ever biosimilar for multiple sclerosis (MS), among other recent actions.
https://acphospitalist.acponline.org/archives/2023/10/04/new-covid-19-boosters-biosimilar-for-ms-oked.htm
4 Oct 2023
1 in 3 adults with new-onset a fib during hospitalization have recurrence within a year
The findings suggest that patients who experience a transient episode of atrial fibrillation during hospitalization need risk stratification and follow-up, according to the authors of the matched cohort study.
https://acphospitalist.acponline.org/archives/2023/10/04/1-in-3-adults-with-new-onset-a-fib-during-hospitalization-have-recurrence-within-a-year.htm
4 Oct 2023
August issue online and in the mail
This issue's main story focuses on hospitalists' role in telemedicine, and inside features cover Parkinson's disease, atrial fibrillation, and chronic obstructive pulmonary disease.
https://acphospitalist.acponline.org/weekly/archives/2019/08/14/5.htm
14 Aug 2019
Review finds 18% mortality in severe DOAC-related bleeding treated with reversal agent
A systematic review looked at 60 studies that evaluated four-factor prothrombin complex concentrates, idarucizumab, or andexanet for the treatment of severe or uncontrolled bleeding in patients on a direct oral anticoagulant (DOAC).
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/4.htm
16 Jun 2021
Guideline-directed care after TIA or nonsevere stroke associated with lower mortality risk
Patients who received brain imaging, carotid artery imaging, antihypertensive intensification, statins, antithrombotics, and anticoagulation for atrial fibrillation after transient ischemic attack (TIA) or nonsevere ischemic stroke had lower risk of mortality.
https://acphospitalist.acponline.org/weekly/archives/2019/07/10/2.htm
10 Jul 2019